Chronic Obstructive Pulmonary Disease: Clinical Trials

2 active not recruiting. 2 Phase 3.

By phase and status

Phase	Trials	Status
Phase 3	2	Active not recruiting 2

Follow Chronic Obstructive Pulmonary Disease: new trials by email Literature Review of Chronic Obstructive Pulmonary Disease trials Research Report on Chronic Obstructive Pulmonary Disease

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD) Astegolimab - Chronic Obstructive Pulmonary Disease	Phase 3	Active not recruiting	Hoffmann-La Roche	2000	2023-06-28	2026-08-14
Effect of Perioperative Bronchodilator in COPD Patients Undergoing Lung Cancer Surgery Vilanterol and Umeclidinium Bromide, Placebo - Chronic Obstructive Pulmonary Disease, Non Small Cell Lung Cancer	Phase 3	Active not recruiting	Samsung Medical Center	204	2021-04-01	2026-06-26

Narrower conditions

Pulmonary Disease, Chronic Obstructive (2)  ·  Carcinoma, Non-Small-Cell Lung (1)

Broader conditions

Chronic Disease (2)  ·  Disease Attributes (2)  ·  Lung Diseases (2)  ·  Lung Diseases, Obstructive (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Respiratory Tract Diseases (2)  ·  Bronchial Neoplasms (1)  ·  Carcinoma, Bronchogenic (1)  ·  Lung Neoplasms (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Respiratory Tract Neoplasms (1)  ·  Thoracic Neoplasms (1)

Interventions

astegolimab (1)  ·  vilanterol (1)

Sponsors

Hoffmann-La Roche (1)  ·  Samsung Medical Center (1)

Countries

South Korea (2)  ·  Argentina (1)  ·  Australia (1)  ·  Austria (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Bulgaria (1)  ·  Canada (1)  ·  Chile (1)  ·  China (1)  ·  Czechia (1)  ·  Denmark (1)  ·  France (1)  ·  Germany (1)  ·  Greece (1)